An expert discusses a trial comparing recombinant interferon alpha-2 with hydroxyurea in patients with myeloproliferative neoplasms (MPNs).
Trine Alma Knudsen, M.D.
Advertisement
Articles by Trine Alma Knudsen, M.D.
Advertisement
Latest Updated Articles
Comparing Two MPN DrugsPublished: June 21st 2018 | Updated:
Advertisement
Advertisement
Trending on CURE
1
Areola Tattooing Helped Stephanie Wachtel Reclaim Confidence After Cancer
2
Keytruda Combo Improves Progression, Survival in Recurrent Ovarian Cancer
3
Postsurgical Opdivo Associated With Long-Term Activity in Melanoma
4
Presurgical Enhertu Combo Elicits Response Benefit in HER2+ Early Breast Cancer
5
